Congratulations to Drewe Lacey (one of our trustees) who has just completed a walk along the Wye valley to raise money for GIST Cancer UK and local rotary clubs. You […]
GIST News
Newsletter – Spring 2024
Welcome to the third edition of our Newsletter which has been designed to be as informative as possible to everyone affected by GIST Cancer. It contains information about our most […]
Phase 2 Trial – Avelumab Plus Regorafenib
Combination treatment with avelumab and regorafenib has shown activity in patients with relapsed/refractory gastrointestinal stromal tumors (GIST), according to research presented at the European Society for Medical Oncology (ESMO) Congress […]
Newsletter – Autumn 2023
Welcome to the second edition of our Newsletter which has been designed to be as informative as possible to everyone affected by GIST Cancer. It contains information about our most […]
Leeds Sessions 2023
Videos of the sessions at the October 2023 Patient Carer meeting held in Leeds are now available on the Patient Meetings 2023 section of this site.
Ripretinib vs Sunitinib 2023
The outcome of the recent Intrigue study which compared the effectiveness and side effects associated with these drugs can be found here.
Managing Side Effects of Therapies 2023
The Life Raft. Group (the US equivalent of GIST Cancer UK) hold a series of online events that may be of interest to patients and carers in the UK. The […]
Scottish Patient/Carer Meeting 2023
The annual Scottish patient meeting will take place on Friday, 1st December 2023 at the Cosla Conference Centre, Verity House, 19 Haymarket Yards, Edinburgh EJ12 5BH. To book a place please […]